BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations

  Ovid Therapeutics Inc. and Graviton Bioscience Corporation today announced the results from their Phase 1 healthy volunteer study evaluating the safety, tolerability, and pharmacokinetic (PK) profile of multiple ascending doses of OV888/GV101 capsule.

  July 1, 2024

   · 

  9 min read
• Kraig Biocraft Laboratories Expands Facilities to Support Spider Silk Production Growth

  Kraig Biocraft Laboratories, Inc., announces that it has achieved full capacity at its current production location. Hitting this milestone was part of Kraig Labs’ expansion plans for the first half of 2024.

  July 1, 2024

   · 

  2 min read
• Robert A. Michael Assumes Role as AbbVie Chief Executive Officer

  AbbVie announced that Robert A. Michael has assumed the role of chief executive officer and has joined AbbVie’s Board of Directors.

  July 1, 2024

   · 

  3 min read
• National Science Foundation Awards Booz Allen $419M Technology Modernization Contract

  Booz Allen Hamilton announced it was awarded a seven-year, $419 million contract with the National Science Foundation for Information Technology Mission Application Support.

  July 1, 2024

   · 

  5 min read
• N-Power Medicine Collaborates with Merck to Expand Oncologist and Patient Access to Clinical Trials

  N-Power Medicine, a company reinventing the clinical trial process, is collaborating with Merck, known as MSD outside the United States and Canada, to enable a greater number of oncologists, and the patients they care for, to participate in clinical research.

  July 1, 2024

   · 

  2 min read
• Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4) - July 01, 2024

  Axogen, Inc. announced making an inducement grant on July 1, 2024, under NASDAQ listing rule 5635 in connection with the hire of a new non-executive employee.

  July 1, 2024

   · 

  3 min read
• Genezen to Acquire uniQure’s Commercial Gene Therapy Manufacturing Operations in Lexington, MA

  Genezen, a best-in-class gene therapy CDMO, announced an agreement to acquire uniQure’s commercial gene therapy operations in Lexington, MA, bringing a strategic manufacturing facility and a world-class team of employees to the company.

  July 1, 2024

   · 

  3 min read
• Finding the sweet spot in brain development

  Not everything in the brain is meant to last. As our brains assemble, trillions of neural connections have to be built or torn down at the right time and place.

  July 1, 2024

   · 

  2 min read
• Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes

  Korro Bio, Inc. announced that it has been added to the Russell 2000®, Russell 3000®, and the Russell Microcap® Indexes as part of the annual reconstitution, effective at the open of US equity markets today, Monday, July 1.

  July 1, 2024

   · 

  6 min read
• Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer

  Merus N.V. today announced the appointment of Fabian Zohren M.D., PhD as Chief Medical Officer (CMO) effective July 1, 2024.

  July 1, 2024

   · 

  6 min read